The Canalith Repositioning Procedure with and without Mastoid Oscillation for the Treatment of Benign Paroxysmal Positional Vertigo

ORL ◽  
2007 ◽  
Vol 69 (5) ◽  
pp. 295-298 ◽  
Author(s):  
Michael J. Ruckenstein ◽  
Neil T. Shepard
Keyword(s):  
Benign Paroxysmal Positional Vertigo ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

scholarly journals Effect of the Canalith Repositioning Procedure on Benign Paroxysmal Positional Vertigo. Posterior Canal Type.

1998 ◽  
Vol 91 (4) ◽  
pp. 341-345
Author(s):  
Ken HAYASHI ◽  
Naoki HAYASHI ◽  
Mamoru SUZUKI ◽  
Tohru TANIGAWA ◽  
Muneo TAKAMOTO ◽  
...  
Keyword(s):  
Benign Paroxysmal Positional Vertigo ◽  
Posterior Canal ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

scholarly journals Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)

2017 ◽  
Vol 156 (3_suppl) ◽  
pp. S1-S47 ◽  
Author(s):  
Neil Bhattacharyya ◽  
Samuel P. Gubbels ◽  
Seth R. Schwartz ◽  
Jonathan A. Edlow ◽  
Hussam El-Kashlan ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Benign Paroxysmal Positional Vertigo ◽  
Radiographic Imaging ◽  
Inappropriate Use ◽  
Central Nervous System Disorders ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

Objective This update of a 2008 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to benign paroxysmal positional vertigo (BPPV), defined as a disorder of the inner ear characterized by repeated episodes of positional vertigo. Changes from the prior guideline include a consumer advocate added to the update group; new evidence from 2 clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials; enhanced emphasis on patient education and shared decision making; a new algorithm to clarify action statement relationships; and new and expanded recommendations for the diagnosis and management of BPPV. Purpose The primary purposes of this guideline are to improve the quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing such as radiographic imaging, and increasing the use of appropriate therapeutic repositioning maneuvers. The guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and it applies to any setting in which BPPV would be identified, monitored, or managed. The target patient for the guideline is aged ≥18 years with a suspected or potential diagnosis of BPPV. The primary outcome considered in this guideline is the resolution of the symptoms associated with BPPV. Secondary outcomes considered include an increased rate of accurate diagnoses of BPPV, a more efficient return to regular activities and work, decreased use of inappropriate medications and unnecessary diagnostic tests, reduction in recurrence of BPPV, and reduction in adverse events associated with undiagnosed or untreated BPPV. Other outcomes considered include minimizing costs in the diagnosis and treatment of BPPV, minimizing potentially unnecessary return physician visits, and maximizing the health-related quality of life of individuals afflicted with BPPV. Action Statements The update group made strong recommendations that clinicians should (1) diagnose posterior semicircular canal BPPV when vertigo associated with torsional, upbeating nystagmus is provoked by the Dix-Hallpike maneuver, performed by bringing the patient from an upright to supine position with the head turned 45° to one side and neck extended 20° with the affected ear down, and (2) treat, or refer to a clinician who can treat, patients with posterior canal BPPV with a canalith repositioning procedure. The update group made a strong recommendation against postprocedural postural restrictions after canalith repositioning procedure for posterior canal BPPV. The update group made recommendations that the clinician should (1) perform, or refer to a clinician who can perform, a supine roll test to assess for lateral semicircular canal BPPV if the patient has a history compatible with BPPV and the Dix-Hallpike test exhibits horizontal or no nystagmus; (2) differentiate, or refer to a clinician who can differentiate, BPPV from other causes of imbalance, dizziness, and vertigo; (3) assess patients with BPPV for factors that modify management, including impaired mobility or balance, central nervous system disorders, a lack of home support, and/or increased risk for falling; (4) reassess patients within 1 month after an initial period of observation or treatment to document resolution or persistence of symptoms; (5) evaluate, or refer to a clinician who can evaluate, patients with persistent symptoms for unresolved BPPV and/or underlying peripheral vestibular or central nervous system disorders; and (6) educate patients regarding the impact of BPPV on their safety, the potential for disease recurrence, and the importance of follow-up. The update group made recommendations against (1) radiographic imaging for a patient who meets diagnostic criteria for BPPV in the absence of additional signs and/or symptoms inconsistent with BPPV that warrant imaging, (2) vestibular testing for a patient who meets diagnostic criteria for BPPV in the absence of additional vestibular signs and/or symptoms inconsistent with BPPV that warrant testing, and (3) routinely treating BPPV with vestibular suppressant medications such as antihistamines and/or benzodiazepines. The guideline update group provided the options that clinicians may offer (1) observation with follow-up as initial management for patients with BPPV and (2) vestibular rehabilitation, either self-administered or with a clinician, in the treatment of BPPV.

Takotsubo Cardiomyopathy and Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo

2010 ◽  
Vol 21 (02) ◽  
pp. 073-077 ◽  
Author(s):  
Selmin Karatayli-Ozgursoy ◽  
Larry B. Lundy ◽  
David A. Zapala ◽  
Keith R. Oken
Keyword(s):  
Chest Pain ◽  
Takotsubo Cardiomyopathy ◽  
Benign Paroxysmal Positional Vertigo ◽  
English Literature ◽  
Left Ventricular ◽  
Apical Ballooning Syndrome ◽  
Positional Vertigo ◽  
Ampulla Cardiomyopathy ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

Background: Takotsubo cardiomyopathy, also known as left ventricular apical ballooning syndrome, ampulla cardiomyopathy, or transient left ventricular dysfunction is characterized by chest pain, electrocardiographic changes, transient left ventricular apical aneurysm, and normal coronary arteries. Tako-tsubo is a round-bottomed, narrow-necked Japanese octopus trap and lends its name to takotsubo cardiomyopathy because of its resemblance to echocardiographic and ventricular angiographic images of the left ventricle in this condition. This appearance takes its source from peculiar, transient regional systolic dysfunction involving the left ventricular apex and mid-ventricle with hyperkinesis of the basal left ventricular segments. Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo caused by peripheral vestibular dysfunction. The symptoms of BPPV are attributed to intralabyrinthine particles, presumed displaced otoconia. Thus, the treatment recommended for BPPV is head repositioning maneuvers. Purpose: To present the first takotsubo cardiomyopathy case in the English literature related to BPPV undergoing canalith repositioning procedure. Conclusion: This report will provide additional information for physicians encountering acute-onset chest pain and vertigo. It will also expand the spectrum of clinical correlates of the increasingly well recognized but poorly understood syndrome, takotsubo cardiomyopathy.

scholarly journals Efficacy of the Canalith Repositioning Procedure in Benign Paroxysmal

2016 ◽  
Vol 27 (2) ◽  
pp. 23-27
Author(s):  
Abul Mansur Md Rezaul Karim ◽  
Md Hasanuzzaman ◽  
Mohammed Abu Yusuf Chowdhury ◽  
Md Abu Tayeb
Keyword(s):  
Benign Paroxysmal Positional Vertigo ◽  
Head Movements ◽  
Control Treatment ◽  
College Hospital ◽  
Positional Vertigo ◽  
Significant Difference ◽  
Group A ◽  
Canalith Repositioning Procedure ◽  
Group B ◽  
Paroxysmal Positional Vertigo

Benign paroxysmal positional vertigo (BPPV) is paroxysms of vertigo occurring with certain head movements, typically looking up or turning over in bed comprising about 20% of Dizziness cases. This study was carried out to evaluate the Efficacy of canalith repositioning procedure(CRP) in BPPV. A randomized clinical trial including 80 patients with BPPV was performed Medicine & Neurology Outpatient Department, Chittagong Medical College Hospital. The patients were randomly divided into two groups. Group A treated by anti-vertigo drug and CRP, Group B treated by anti-vertigo drug alone. All patients were followed up in hospital at one week after & 4 weeks. The rates of effectiveness of CRP treatment and the control treatment for were 86.8% and 59.4%, respectively. There was a significant difference (27.4%) in the outcomes of the CRP & control groups (P <.05). Mean total drug use for the group A was 10 ± 1, whereas it was 30 ± 1.5 for group B, mean difference = 20 (P < .001, highly Significant). At 4 Weeks, subjective improvement and symptom free occurred in 94.7% patients in group A and 73% patients in group B (difference21.7%). Complications in the CRP group were observed in 10.6% of the patients. This study demonstrated that canalith repositioning procedure (CRP) was effective in the treatment for benign paroxysmal positional vertigo insofar as it provided faster recovery & low drug dependence. Complications of CRP were limited to 10.6% of patients.Medicine Today 2015 Vol.27(2): 23-27

Sign in / Sign up

Export Citation Format

Share Document